CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL
Clinical trial NCT04303247 · UNKNOWN
Trial details
- NCT number
- NCT04303247
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.